CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Open-market sale President and CEO sold 41,070 shares at an average $1.13 ($46,501)
- 4 Open-market sale Chief Operations Officer sold 9,784 shares at an average $1.13 ($11,077)
- 4 Open-market sale Chief Scientific Officer sold 9,784 shares at an average $1.13 ($11,077)
- 4 Open-market sale Chief Medical Officer sold 11,644 shares at an average $1.13 ($13,185)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 282,800 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Operations Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 100,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 4,522 shares at $1.33 ($6,014)
- 4 Option exercise President and CEO acquired 10,938 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 7 of 21 · 410 filings